| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |